Understanding nontuberculous mycobacterial lung disease: It's been a long time coming

F1000Research

Volumn 5, Issue , 2016, Pages

  Griffith, David E ^a   Aksamit, Timothy R ^b  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CYCLOSERINE; ETHIONAMIDE; MACROLIDE;

ATYPICAL MYCOBACTERIUM; BACTERIAL VIRULENCE; HUMAN; LABORATORY TEST; LUNG DISEASE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; SPECIES IDENTIFICATION; TREATMENT RESPONSE;

EID: 85007575078     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.9272.1     Document Type: Review

References (62)

1. Adjemian J Prevots DR Gallagher J: Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease. Ann Am Thorac Soc. 2014;11(1):9-16. 24236749 10.1513/AnnalsATS.201304-085OC 3972983
2. Runyon EH: Typical myobacteria: their classification. Am Rev Respir Dis. 1965;91:288-9. 14253182
3. Runyon EH: Identification of mycobacterial pathogens utilizing colony characteristics. Am J Clin Pathol. 1970;54(4):578-86. 5471228 10.1093/ajcp/54.4.578
4. Wolinsky E: Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis. 1979;119(1):107-59. 369415
5. Wallace RJ O'Brien R Glassroth J: Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am Rev Respir Dis. 1990;142(4):940-53. 2282111 10.1164/ajrccm/142.4.940
6. Jost KC Jr Dunbar DF Barth SS: Identification of Mycobacterium tuberculosis and M. avium complex directly from smear-positive sputum specimens and BACTEC 12B cultures by high-performance liquid chromatography with fluorescence detection and computer-driven pattern recognition models. J Clin Microbiol. 1995;33(5):1270-7. 7615740 228144
7. Louro AP Waites KB Georgescu E: Direct identification of Mycobacterium avium complex and Mycobacterium gordonae from MB/BacT bottles using AccuProbe. J Clin Microbiol. 2001;39(2):570-3. 11158108 10.1128/JCM.39.2.570-573.2001 87777
8. Pauls RJ Turenne CY Wolfe JN: A high proportion of novel mycobacteria species identified by 16S rDNA analysis among slowly growing AccuProbe-negative strains in a clinical setting. Am J Clin Pathol. 2003;120(4):560-6. 14560567 10.1309/VF40-1U7H-7DHE-0FRE
9. Cloud JL Carroll KC Cohen S: Interpretive criteria for use of AccuProbe for identification of Mycobacterium avium complex directly from 7H9 broth cultures. J Clin Microbiol. 2005;43(7):3474-8. 16000482 10.1128/JCM.43.7.3474-3478.2005 1169162
10. Griffith DE Brown-Elliott BA Benwill JL: Mycobacterium abscessus. "Pleased to meet you, hope you guess my name...". Ann Am Thorac Soc. 2015;12(3):436-9. 25643064 10.1513/AnnalsATS.201501-015OI
11. Tettelin H Davidson RM Agrawal S: High-level relatedness among Mycobacterium abscessus subsp. massiliense strains from widely separated outbreaks. Emerg Infect Dis. 2014;20(3):364-71. 24565502 10.3201/eid2003.131106 3944860
12. van Ingen J Boeree MJ Dekhuijzen PN: Environmental sources of rapid growing nontuberculous mycobacteria causing disease in humans. Clin Microbiol Infect. 2009;15(10):888-93. 19845700 10.1111/j.1469-0691.2009.03013.x
13. Wallace RJ Jr Iakhiaeva E Williams MD: Absence of Mycobacterium intracellulare and presence of Mycobacterium chimaera in household water and biofilm samples of patients in the United States with Mycobacterium avium complex respiratory disease. J Clin Microbiol. 2013;51(6):1747-52. 23536397 10.1128/JCM.00186-13 3716115
14. Wallace RJ Jr Zhang Y Brown BA: Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis. Am J Respir Crit Care Med. 1998;158(4):1235-44. 9769287 10.1164/ajrccm.158.4.9712098
15. O'Brien RJ Geiter LJ Snider DE Jr: The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis. 1987;135(5):1007-14. 3579001
16. O'Brien RJ: The epidemiology of nontuberculous mycobacterial disease. Clin Chest Med. 1989;10(3):407-18. 2673649
17. Griffith DE Aksamit T Brown-Elliott BA: An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367-416. 17277290 10.1164/rccm.200604-571ST
18. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med. 1997;156(2 pt 2):S1-25. 9279284 10.1164/ajrccm.156.2.atsstatement
19. Griffith DE Brown-Elliott BA Wallace RJ Jr: Diagnosing nontuberculous mycobacterial lung disease. A process in evolution. Infect Dis Clin North Am. 2002;16(1):235-49. 11917815 10.1016/S0891-5520(03)00054-0
20. Jankovic M Sabol I Zmak L: Microbiological criteria in non-tuberculous mycobacteria pulmonary disease: a tool for diagnosis and epidemiology. Int J Tuberc Lung Dis. 2016;20(7):934-40. 27287647 10.5588/ijtld.15.0633
21. Cassidy PM Hedberg K Saulson A: Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis. 2009;49(12):e124-9. 19911942 10.1086/648443
22. Winthrop KL McNelley E Kendall B: Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med. 2010;182(7):977-82. 20508209 10.1164/rccm.201003-0503OC
23. Winthrop KL Varley CD Ory J: Pulmonary disease associated with nontuberculous mycobacteria, Oregon, USA. Emerg Infect Dis. 2011;17(9):1760-1. 21888816 10.3201/eid1709.101929 3322068
24. Adjemian J Olivier KN Seitz AE: Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med. 2012;185(8):881-6. 22312016 10.1164/rccm.201111-2016OC 3360574
25. Prevots DR Shaw PA Strickland D: Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med. 2010;182(7):970-6. 20538958 10.1164/rccm.201002-0310OC 2970866
26. Hoefsloot W van Ingen J Andrejak C: The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J. 2013;42(6):1604-13. 23598956 10.1183/09031936.00149212
27. Ito Y Hirai T Fujita K: Increasing patients with pulmonary Mycobacterium avium complex disease and associated underlying diseases in Japan. J Infect Chemother. 2015;21(5):352-6. 25640532 10.1016/j.jiac.2015.01.004
28. Hu P Bai L Liu F: Evaluation of the Xpert MTB/RIF assay for diagnosis of tuberculosis and rifampin resistance in county-level laboratories in Hunan province, China. Chin Med J (Engl). 2014;127(21):3744-50. 25382330
29. Wu J Zhang Y Li J: Increase in nontuberculous mycobacteria isolated in Shanghai, China: results from a population-based study. PLoS One. 2014;9(10):e109736. 25330201 10.1371/journal.pone.0109736 4199589
30. Shao Y Chen C Song H: The epidemiology and geographic distribution of nontuberculous mycobacteria clinical isolates from sputum samples in the eastern region of China. PLoS Negl Trop Dis. 2015;9(3):e0003623. 25775117 10.1371/journal.pntd.0003623 4361326
31. Collins CH Grange JM Yates MD: Mycobacteria in water. J Appl Bacteriol. 1984;57(2):193-211. 6389461 10.1111/j.1365-2672.1984.tb01384.x
32. Meissner PS Falkinham JO 3rd: Plasmid DNA profiles as epidemiological markers for clinical and environmental isolates of Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum. J Infect Dis. 1986;153(2):325-31. 3944484 10.1093/infdis/153.2.325
33. Fujita K Ito Y Hirai T: Genetic relatedness of Mycobacterium avium-intracellulare complex isolates from patients with pulmonary MAC disease and their residential soils. Clin Microbiol Infect. 2013;19(6):537-41. 22712883 10.1111/j.1469-0691.2012.03929.x
34. Aitken ML Limaye A Pottinger P: Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. Am J Respir Crit Care Med. 2012;185(2):231-2. 22246710 10.1164/ajrccm.185.2.231
35. Bryant JM Grogono DM Greaves D: Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Lancet. 2013;381(9877):1551-60. 23541540 10.1016/S0140-6736(13)60632-7 3664974
36. Prince DS Peterson DD Steiner RM: Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med. 1989;321(13):863-8. 2770822 10.1056/NEJM198909283211304
37. Griffith DE Aksamit TR: Bronchiectasis and nontuberculous mycobacterial disease. Clin Chest Med. 2012;33(2):283-95. 22640846 10.1016/j.ccm.2012.02.002
38. Fleshner M Olivier KN Shaw PA: Mortality among patients with pulmonary non-tuberculous mycobacteria disease. Int J Tuberc Lung Dis. 2016;20(5):582-7. 27084809 10.5588/ijtld.15.0807
39. Szymanski EP Leung JM Fowler CJ: Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease. Am J Respir Crit Care Med. 2015;192(5):618-28. 26038974 10.1164/rccm.201502-0387OC 4595692
40. Iseman MD Corpe RF O'Brien RJ: Disease due to Mycobacterium avium-intracellulare. Chest. 1985;87(2 Suppl):139S-49. 3917895 10.1378/chest.87.2_Supplement.139S
41. Horsburgh CR Jr Mason UG 3rd Heifets LB: Response to therapy of pulmonary Mycobacterium avium-intracellulare infection correlates with results of in vitro susceptibility testing. Am Rev Respir Dis. 1987;135(2):418-21. 3813205
42. Hawkins CC Gold JW Whimbey E: Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1986;105(2):184-8. 3729201 10.7326/0003-4819-105-2-184
43. Mycobacterioses and the acquired immunodeficiency syndrome. Joint Position Paper of the American Thoracic Society and the Centers for Disease Control. Am Rev Respir Dis. 1987;136(2):492-6. 3304048 10.1164/ajrccm/136.2.492
44. Horsburgh CR Jr Selik RM: The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am Rev Respir Dis. 1989;139(1):4-7. 2912355 10.1164/ajrccm/139.1.4
45. Chin DP Reingold AL Stone EN: The impact of Mycobacterium avium complex bacteremia and its treatment on survival of AIDS patients--a prospective study. J Infect Dis. 1994;170(3):578-84. 7915749 10.1093/infdis/170.3.578
46. Shafran SD Singer J Zarowny DP: A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group. N Engl J Med. 1996;335(6):377-83. 8676931 10.1056/NEJM199608083350602
47. Chaisson RE Keiser P Pierce M: Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection. AIDS. 1997;11(3):311-7. 9147422 10.1097/00002030-199703110-00008
48. Wallace RJ Jr Brown BA Griffith DE: Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients. Am J Respir Crit Care Med. 1996;153(6 Pt 1):1766-72. 8665032 10.1164/ajrccm.153.6.8665032
49. Wallace RJ Jr Brown BA Griffith DE: Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. Am J Respir Crit Care Med. 1994;149(5):1335-41. 8173775 10.1164/ajrccm.149.5.8173775
50. Griffith DE Brown BA Girard WM: Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus. Clin Infect Dis. 1996;23(5):983-9. 8922790 10.1093/clinids/23.5.983
51. Wallace RJ Jr Brown-Elliott BA McNulty S: Macrolide/Azalide therapy for nodular/bronchiectatic Mycobacterium avium complex lung disease. Chest. 2014;146(2):276-82. 24457542 10.1378/chest.13-2538 4694082
52. Jeong BH Jeon K Park HY: Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2015;191(1):96-103. 25393520 10.1164/rccm.201408-1545OC
53. Kobashi Y Abe M Mouri K: Clinical usefulness of combination chemotherapy for pulmonary Mycobacterium avium complex disease. J Infect. 2010. 21094662
54. Kobashi Y Matsushima T: The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan - including a follow-up study. Respiration. 2007;74(4):394-400. 16954651 10.1159/000095674
55. Kobashi Y Yoshida K Miyashita N: Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates. J Infect Chemother. 2006;12(4):195-202. 16944258 10.1007/s10156-006-0457-8
56. van Ingen J, Ferro BE, Hoefsloot W: Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence. Expert Rev Anti Infect Ther. 2013; 11(10):1065-77. 24124798 10.1586/14787210.2013.830413
57. Brown-Elliott BA, Nash KA, Wallace RJ Jr: Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev. 2012;25(3):545-82. 22763637 10.1128/CMR.05030-11 3416486
58. van Ingen J, Boeree MJ, van Soolingen D: Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria. Drug Resist Updat. 2012;15(3):149-61. 22525524 10.1016/j.drup.2012.04.001
59. Brown-Elliott BA, Iakhiaeva E, Griffith DE: In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates. J Clin Microbiol. 2013;51(10):3389-94. 23946523 10.1128/JCM.01612-13 3811650
60. Nash KA, Brown-Elliott BA, Wallace RJ Jr: A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother. 2009;53(4):1367-76. 19171799 10.1128/AAC.01275-08 2663066
61. Griffith DE, Brown-Elliott BA, Langsjoen B: Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2006;174(8):928-34. 16858014 10.1164/rccm.200603-450OC
62. Boyle DP, Zembower TR, Reddy S: Comparison of Clinical Features, Virulence, and Relapse among Mycobacterium avium Complex Species. Am J Respir Crit Care Med. 2015;191(11):1310-7. 25835090 10.1164/rccm.201501-0067OC